RecruitingNot applicableNCT06256575

Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Primus Pharmaceuticals
Principal Investigator
Lukban
Primus Pharmaceuticals
Intervention
Diosmin(combination_product)
Enrollment
45 enrolled
Eligibility
18 years · All sexes
Timeline
20252027

Study locations (5)

Collaborators

KGK Science Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06256575 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis

← Back to all trials